Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS)

CUSIP: 00509G209

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
71,531,081
Total 13F shares
43,605,225
Share change
-86,415
Total reported value
$107,681,203
Put/Call ratio
1297%
Price per share
$2.48
Number of holders
72
Value change
-$212,803
Number of buys
32
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 00509G209?
CUSIP 00509G209 identifies ABOS - Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS) as of Q3 2024

As of 30 Sep 2024, Acumen Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ABOS) was held by 72 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,605,225 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., FRANKLIN RESOURCES INC, Sands Capital Ventures, LLC, BlackRock, Inc., Rock Springs Capital Management LP, FMR LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Knollwood Investment Advisory, LLC, and Alyeska Investment Group, L.P.. This page lists 72 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.